Sanofi announces new vaccine project as Australia begins animal tests
France’s Sanofi Pasteur and US biotechnology company Translate Bio have joined the race to develop a vaccine for SARS-CoV-2, the coronavirus behind COVID-19.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
14 April 2020 Sanofi and GlaxoSmithKline are pooling resources to create a vaccine for COVID-19, in what they call an “unprecedented” collaboration between the two pharma companies.
6 April 2020 The Biotechnology Innovation Organization has converted its 2020 international convention into an entirely online experience, BIO Digital.
19 February 2020 Sanofi’s vaccine unit has united with the US Department of Health and Human Services to develop a vaccine for the COVID-19 virus, which has so far killed more than 2,000 people worldwide.